TNF and Dravet syndrome: IPA-predicted upstream regulators for all four models included activation by the proinflammatory cytokine tumor necrosis factor (TNF; Table S6), of interest because individuals with DS show evidence of increased TNFα signaling in blood (Sullivan et al., 2017; Zhang et al., 2017).